Atlas Trials

A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer Patients

Clinical trial NCT06788197 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06788197
Sponsor
Henan Cancer Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast CancerLocally Advanced or Metastatic Breast Cancer
Start date
2025-03-01
Primary completion
2028-03-31
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.